Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children

[21] Pavcnik-Arnol M(2003)Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients Crit Care 7 R154-R159

[22] Hojker S(2006)Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study Crit Care 10 R53-R62

[23] Derganc M(1997)The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome Clin Diagn Lab Immunol 4 113-116

[24] Lopez Sastre JB(2002)Increased levels of lipopolysaccharide binding protein in plasma in children with Kawasaki disease Clin Diagn Lab Immunol 9 205-206

[25] Perez Solis D(1997)Fibronectin enhances in vitro lipopolysaccharide priming of polymorphonuclear leukocytes Blood 89 4182-4189

[26] Roques Serradilla V(2005)Evaluation of a newly identified soluble CD14 subtype as a marker of sepsis J Infect Chemother 11 234-238

[27] Fernandez Colomer B(2000)The detection and interpretation of endotoxaemia Intensive Care Med 26 S51-S56

[28] Coto Cotallo GD(1997)Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 937-944

[29] Vidal XK(2004)CD14 is an acute-phase protein J Immunol 172 4470-4479

[30] Narabona Lopez E(2005)Scope and epidemiology of pediatric sepsis Pediatr Crit Care Med 6 S3-S5

[21] Pavcnik-Arnol M(2003)Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients Crit Care 7 R154-R159

[22] Hojker S(2006)Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study Crit Care 10 R53-R62

[23] Derganc M(1997)The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome Clin Diagn Lab Immunol 4 113-116

[24] Lopez Sastre JB(2002)Increased levels of lipopolysaccharide binding protein in plasma in children with Kawasaki disease Clin Diagn Lab Immunol 9 205-206

[25] Perez Solis D(1997)Fibronectin enhances in vitro lipopolysaccharide priming of polymorphonuclear leukocytes Blood 89 4182-4189

[26] Roques Serradilla V(2005)Evaluation of a newly identified soluble CD14 subtype as a marker of sepsis J Infect Chemother 11 234-238

[27] Fernandez Colomer B(2000)The detection and interpretation of endotoxaemia Intensive Care Med 26 S51-S56

[28] Coto Cotallo GD(1997)Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 937-944

[29] Vidal XK(2004)CD14 is an acute-phase protein J Immunol 172 4470-4479

[30] Narabona Lopez E(2005)Scope and epidemiology of pediatric sepsis Pediatr Crit Care Med 6 S3-S5